🔗 Share this article Users Stopping Weight-Loss Injections Put On Pounds Four Times Faster Than People Using Diet and Exercise Weight management often requires long-term strategies. New research indicates that patients who come off new weight-loss injections like Mounjaro or Wegovy can put back on shed pounds far faster than those who end traditional lifestyle regimens. Published data in a major medical journal shows that while obese individuals often shed a large proportion of their total mass while on the medication, the weight is regained at an estimated rate of 0.8 kg per month after stopping. "Users purchasing such drugs must be cognizant of the danger of quick weight regain when the treatment is stopped," cautioned researcher Dr. Susan Jebb. That rate of regain implies a return to pre-treatment weight in about a year and a half. Comparing Therapies The study, which examined 37 of trials involving over 9,000 of patients, compared the results of these new drugs with other pills. Researchers note that individuals who shed pounds through diet and exercise generally see a less rapid weight regain—approximately 100 grams monthly—post-intervention. Explaining the Fast Rebound Experts suggest the mode of action of the jabs is key to understanding the amplified regain. GLP-1 drugs copy a natural hormone called GLP-1, which controls hunger. "Artificially providing GLP-1 concentrations several times higher than normal may cause the body to generate a reduced amount of its own natural hormone, and may also reduce sensitivity to its actions," explained Dr. Adam Collins, a dietetics expert. "Withdrawal of this medication leads to hunger is uncontrolled, making excessive eating far more likely." A Lifelong Issue? Health authorities recommend the injections for individuals with weight-linked medical conditions, alongside prescribed lifestyle changes. Professionals say that, considering the high risk of weight regain, the therapy should be considered life-long. This opinion is supported by pharmaceutical companies, who note that the findings "emphasize the persistent nature of obesity," comparing it to managing conditions like high blood pressure. Patient Experiences Users who have stopped the jabs explain a intense resurgence of hunger. "It was like something that goes on and I was suddenly starving," recalled a patient. The struggle is worsened if users have not established lasting dietary or behavioural modifications during treatment. Growing Use Recent estimates suggest that a significant number of people in the UK have tried these injections in the past year, with interest remaining high. Adoption is greater among females compared to males. The middle-aged demographic shows the highest level of interest. Many access the drugs through private healthcare rather than public health services. In conclusion, clinicians stress that while these medications are powerful agents for shedding pounds, they are not a magic solution and lasting health benefits likely depends on ongoing lifestyle management.
Weight management often requires long-term strategies. New research indicates that patients who come off new weight-loss injections like Mounjaro or Wegovy can put back on shed pounds far faster than those who end traditional lifestyle regimens. Published data in a major medical journal shows that while obese individuals often shed a large proportion of their total mass while on the medication, the weight is regained at an estimated rate of 0.8 kg per month after stopping. "Users purchasing such drugs must be cognizant of the danger of quick weight regain when the treatment is stopped," cautioned researcher Dr. Susan Jebb. That rate of regain implies a return to pre-treatment weight in about a year and a half. Comparing Therapies The study, which examined 37 of trials involving over 9,000 of patients, compared the results of these new drugs with other pills. Researchers note that individuals who shed pounds through diet and exercise generally see a less rapid weight regain—approximately 100 grams monthly—post-intervention. Explaining the Fast Rebound Experts suggest the mode of action of the jabs is key to understanding the amplified regain. GLP-1 drugs copy a natural hormone called GLP-1, which controls hunger. "Artificially providing GLP-1 concentrations several times higher than normal may cause the body to generate a reduced amount of its own natural hormone, and may also reduce sensitivity to its actions," explained Dr. Adam Collins, a dietetics expert. "Withdrawal of this medication leads to hunger is uncontrolled, making excessive eating far more likely." A Lifelong Issue? Health authorities recommend the injections for individuals with weight-linked medical conditions, alongside prescribed lifestyle changes. Professionals say that, considering the high risk of weight regain, the therapy should be considered life-long. This opinion is supported by pharmaceutical companies, who note that the findings "emphasize the persistent nature of obesity," comparing it to managing conditions like high blood pressure. Patient Experiences Users who have stopped the jabs explain a intense resurgence of hunger. "It was like something that goes on and I was suddenly starving," recalled a patient. The struggle is worsened if users have not established lasting dietary or behavioural modifications during treatment. Growing Use Recent estimates suggest that a significant number of people in the UK have tried these injections in the past year, with interest remaining high. Adoption is greater among females compared to males. The middle-aged demographic shows the highest level of interest. Many access the drugs through private healthcare rather than public health services. In conclusion, clinicians stress that while these medications are powerful agents for shedding pounds, they are not a magic solution and lasting health benefits likely depends on ongoing lifestyle management.